CARDINAL 3PL — Diphenhydramine Importer Profile
Pharmaceutical Importer · #1 buyer for Diphenhydramine · $1.9M import value · 38 shipments · UNITED STATES · DGFT Verified
CARDINAL 3PL is the #1 importer of Diphenhydramine from India with $1.9M in import value and 38 verified shipments. CARDINAL 3PL holds a 5.9% market share in Diphenhydramine imports based in UNITED STATES. The company sources from 1 verified supplier across 26 formulations shipped to 2 countries. Overall, CARDINAL 3PL imports 2 pharmaceutical products worth $2.5M across 2 therapeutic categories.
CARDINAL 3PL — Diphenhydramine Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Diphenhydramine to CARDINAL 3PL?
Verified from 38 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MICRO LABS LIMITED | $1.9M | 38 | 100.0% |
CARDINAL 3PL sources Diphenhydramine from 1 verified Indian supplier based on 38 customs records. The primary supplier is MICRO LABS LIMITED accounting for 100.0% of imports.
How Does CARDINAL 3PL Compare to Nearest Diphenhydramine Importers?
Buyers ranked immediately above and below #1 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | SPIRIT PHARMACEUTICALS LLC | UNITED STATES | $4.3M | 99 | $43.8K |
| 3 | KWADWOTENG VENTURE | GHANA | $2.8M | 59 | $46.7K |
| 1 | CARDINAL 3PL ★ | UNITED STATES | $1.9M | 38 | $50.0K |
| 5 | GRANULES CONSUMER HEALTH | UNITED STATES | $1.8M | 66 | $27.3K |
| 4 | SPIRIT PHARMACEUTICALS LLC, | UNITED STATES | $1.5M | 30 | $50.0K |
CARDINAL 3PL ranks #1 among 289 Diphenhydramine importers from India. Average shipment value of $50.0K compared to the market average of $62.6K. The closest competitors by value are SPIRIT PHARMACEUTICALS LLC and KWADWOTENG VENTURE.
Where Does CARDINAL 3PL Import Diphenhydramine To?
Destination countries from 38 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.8M | 36 | 94.7% |
| UNITED STATES OF AMERICA | $100.0K | 2 | 5.3% |
CARDINAL 3PL imports Diphenhydramine to 2 countries. The primary destination is UNITED STATES receiving 94.7% of shipments worth $1.8M.
What Diphenhydramine Formulations Does CARDINAL 3PL Import?
| Formulation | Value | Shipments |
|---|---|---|
| DIPHENHYDRAMINE HCL INJECTION USP 50mg/m | $250.0K | 5 |
| DIPHENHYDRAMINE HCL INJECTION USP 50MG/M | $150.0K | 3 |
| DIPHENHYDRAMINE HCL INJECTION USP 50MG/ML ( 25X1ML ) ( QTY- 25294.000 )PCS | $150.0K | 3 |
| DIPHENHYDRAMINE HYDROCHLORIDE INJECTIONUSP 50MG/ML (25X1ML) - TAX INVOICE NO: 714201047 DT: 29.04.2024 | $150.0K | 3 |
| DIPHENHYDRAMINE HCL INJECTION USP 50MG/ML (5X1ML) - TAX INVOICE NO: 714201041 DT: 22.04.2024 | $142.9K | 3 |
| DIPHENHYDRAMINE HYDROCHLORIDE INJECTION | $50.0K | 1 |
| DIPHENHYDRAMINE HCL INJECTION USP 50mg ml 25X1ML QTY 14020 000 | $50.0K | 1 |
| DIPHENHYDRAMINE HCL INJECTION USP 50mg ml 5X1ML QTY 23688 000 | $50.0K | 1 |
| DIPHENHYDRAMINE HYDROCHLORIDE INJECTIONUSP 50MG/ML( 25X1ML ) ( QTY-6398.000 ) | $50.0K | 1 |
| DIPHENHYDRAMINE HCL INJECTION USP 50MG/ML( 25X1ML ) ( QTY- 18845.000 ) | $50.0K | 1 |
CARDINAL 3PL imports 26 distinct Diphenhydramine formulations from India. The top formulation is DIPHENHYDRAMINE HCL INJECTION USP 50mg/m with 5 shipments worth $250.0K.
Regulatory Requirements: Importing Diphenhydramine into United States
What CARDINAL 3PL and other importers must comply with to import Diphenhydramine from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Diphenhydramine
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Diphenhydramine from India and How Much Does CARDINAL 3PL Import?
India exported $18.1M worth of Diphenhydramine through 1,430 shipments from 178 suppliers to 82 countries, serving 289 buyers globally. CARDINAL 3PL imports $1.9M of this total, accounting for 5.9% of India's Diphenhydramine exports with 38 shipments from UNITED STATES. This is verified from 38 customs shipment records covering 26 distinct formulations.
What Is the Average Order Value for CARDINAL 3PL's Diphenhydramine Imports?
CARDINAL 3PL's average Diphenhydramine order value is $49.8K per consignment, based on 38 shipments totaling $1.9M. CARDINAL 3PL is based in UNITED STATES and ranks #1 among all Diphenhydramine importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Diphenhydramine to CARDINAL 3PL?
CARDINAL 3PL sources Diphenhydramine from 1 verified Indian supplier: MICRO LABS LIMITED ($1.9M, 100.0%). This is based on 38 customs records.
How Does CARDINAL 3PL Compare to Other Diphenhydramine Importers?
CARDINAL 3PL ranks #1 among 289 Diphenhydramine importers from India with a 5.9% market share. The top 3 importers are SPIRIT PHARMACEUTICALS LLC ($4.3M), KWADWOTENG VENTURE ($2.8M), CARDINAL 3PL ($1.9M). CARDINAL 3PL processed 38 shipments from UNITED STATES.
About CARDINAL 3PL
CARDINAL 3PL imports 2 products worth $2.5M. Beyond Diphenhydramine, top products include Verapamil. View the complete CARDINAL 3PL profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Diphenhydramine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Diphenhydramine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: CARDINAL 3PL matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as CARDINAL 3PL's capped import value divided by total capped export value for Diphenhydramine across all Indian exporters.
- 5.Verified Records: This page is backed by 38 individual customs records matching CARDINAL 3PL importing Diphenhydramine, covering 26 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 82+ countries, 289+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Diphenhydramine Import Data for CARDINAL 3PL
Access order-level details, pricing data, supplier connections, and competitive analysis for CARDINAL 3PL's Diphenhydramine imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
CARDINAL 3PL
Full Company Profile →
2 products · $2.5M total trade · 2 categories
CARDINAL 3PL × Diphenhydramine
Verified from customs records
Company Overview
Top Products by CARDINAL 3PL
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for CARDINAL 3PL.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Diphenhydramine. For current order-level data, contact TransData Nexus.